Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily pretreated PTCL population Responses highest in ...
Combining cord blood transplant with a pooled stem cell product to treat blood diseases shows promise in improving efficacy, safety and accessibility for patients needing a stem cell transplant.
Selective JAK1 Inhibitors for Treatment of Atopic Dermatitis Review the role of the JAK/STAT pathway in atopic dermatitis, and the pharmacology of the JAK1 inhibitors upadacitinib and abrocitinib, ...
6 Health and Social Research Center, Universidad de Castilla La-Mancha, Cuenca, Spain Objective To examine the predictive validity of field-based muscular strength tests in relation to incident ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...
Biotia, a company advancing infectious disease diagnostics for challenging infections, today announced the publication of a pivotal clinical validation study in the American Society for Microbiology ...
Please provide your email address to receive an email when new articles are posted on . In an editorial published in the Clinical Journal of the American Society of Nephrology, nephrologists Mark E.
WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA ® (finerenone) significantly reduced urine ...
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who ...